loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 206947 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 EISAI INC (2)

filter

01 CAPSULE;ORAL (2)

filter

01 RX (2)

filter

01 LENVIMA (2)

filter

01 Yes (2)

URL Supplier Web Content
CAPSULE; ORAL
EQ 10MG BASE
2015-02-13
206947
LENVIMA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 4MG BASE
2015-02-13
206947
LENVIMA
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 206947

Looking for FDA Orange Book APPLICATION 206947 2

19

Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LENVATINIB MESYLATE, with a corresponding application number 206947.

Regulatory Information RX

With a dosage strength EQ 10MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 2015-02-13

18

Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LENVATINIB MESYLATE, with a corresponding application number 206947.

Regulatory Information RX

With a dosage strength EQ 4MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug Yes

Approved since 2015-02-13

Post Enquiry
POST ENQUIRY